These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19217919)

  • 1. Intracellular signaling pathways involved in inhibition of PAI-1 expression by CNP in endothelial cells.
    Jerczynska H; Pawlowska Z
    Regul Pept; 2009 Jun; 155(1-3):150-5. PubMed ID: 19217919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells.
    Ozasa A; Komatsu Y; Yasoda A; Miura M; Sakuma Y; Nakatsuru Y; Arai H; Itoh N; Nakao K
    Bone; 2005 Jun; 36(6):1056-64. PubMed ID: 15869918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
    Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
    Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells.
    Mukai Y; Wang CY; Rikitake Y; Liao JK
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1937-42. PubMed ID: 17172275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-type natriuretic peptide attenuates LPS-induced endothelial activation: involvement of p38, Akt, and NF-κB pathways.
    Chen G; Zhao J; Yin Y; Wang B; Liu Q; Li P; Zhao L; Zhou H
    Amino Acids; 2014 Dec; 46(12):2653-63. PubMed ID: 25096521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
    Hamaguchi E; Takamura T; Shimizu A; Nagai Y
    J Pharmacol Exp Ther; 2003 Dec; 307(3):987-94. PubMed ID: 14534369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways.
    Tokudome T; Horio T; Soeki T; Mori K; Kishimoto I; Suga S; Yoshihara F; Kawano Y; Kohno M; Kangawa K
    Endocrinology; 2004 May; 145(5):2131-40. PubMed ID: 14749356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways.
    Demyanets S; Kaun C; Rychli K; Rega G; Pfaffenberger S; Afonyushkin T; Bochkov VN; Maurer G; Huber K; Wojta J
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1962-8. PubMed ID: 17604327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Role of cGMP in the regulation of the plasminogen system.
    Bouchie JL; Hansen H; Feener EP
    Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1771-9. PubMed ID: 9812917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-type natriuretic peptide regulation of guanosine-3',5'-cyclic monophosphate production in human endothelial cells.
    Rautureau Y; Gowers I; Wheeler-Jones CP; Baxter GF
    Auton Autacoid Pharmacol; 2010 Jul; 30(3):185-92. PubMed ID: 20085572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic peptides reduce plasminogen activator inhibitor-1 expression in human endothelial cells.
    Pawłowska Z; Jerczyńska H; Szemraj J; Barańska P; Swiatkowska M; Cierniewski CS
    Cell Mol Biol Lett; 2002; 7(4):1153-7. PubMed ID: 12511982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial C-Type Natriuretic Peptide Acts on Pericytes to Regulate Microcirculatory Flow and Blood Pressure.
    Špiranec K; Chen W; Werner F; Nikolaev VO; Naruke T; Koch F; Werner A; Eder-Negrin P; Diéguez-Hurtado R; Adams RH; Baba HA; Schmidt H; Schuh K; Skryabin BV; Movahedi K; Schweda F; Kuhn M
    Circulation; 2018 Jul; 138(5):494-508. PubMed ID: 29626067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natriuretic peptide activation of extracellular regulated kinase 1/2 (ERK1/2) pathway by particulate guanylyl cyclases in GH3 somatolactotropes.
    Jonas KC; Melrose T; Thompson IR; Baxter GF; Lipscomb VJ; Niessen SJ; Lawson C; McArdle CA; Roberson MS; McGonnell IM; Wheeler-Jones CP; Fowkes RC
    Cell Tissue Res; 2017 Sep; 369(3):567-578. PubMed ID: 28451751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin inhibits tissue factor expression and enhances tissue factor pathway inhibitor expression in human endothelial cells.
    Chen YJ; Zhang LQ; Wang GP; Zeng H; Lü B; Shen XL; Jiang ZP; Chen FP
    Thromb Haemost; 2008 Aug; 100(2):291-300. PubMed ID: 18690350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
    Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
    Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ammonia inhibits the C-type natriuretic peptide-dependent cyclic GMP synthesis and calcium accumulation in a rat brain endothelial cell line.
    Konopacka A; Zielińska M; Albrecht J
    Neurochem Int; 2008 May; 52(6):1160-6. PubMed ID: 18222015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natriuretic peptide receptor-3 underpins the disparate regulation of endothelial and vascular smooth muscle cell proliferation by C-type natriuretic peptide.
    Khambata RS; Panayiotou CM; Hobbs AJ
    Br J Pharmacol; 2011 Sep; 164(2b):584-97. PubMed ID: 21457229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic peptides regulate the expression of tissue factor and PAI-1 in endothelial cells.
    Yoshizumi M; Tsuji H; Nishimura H; Masuda H; Kunieda Y; Kawano H; Kimura S; Sugano T; Kitamura H; Nakagawa K; Nakagawa M
    Thromb Haemost; 1999 Nov; 82(5):1497-503. PubMed ID: 10595644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of C-type natriuretic peptide on the differentiation of cardiac fibroblasts, and secretion of monocyte chemoattractant protein-1 and plasminogen activator inhibitor-1.
    Li ZQ; Liu YL; Li G; Li B; Liu Y; Li XF; Liu AJ
    Mol Med Rep; 2015 Jan; 11(1):159-65. PubMed ID: 25352084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells.
    Sangle GV; Zhao R; Shen GX
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1243-54. PubMed ID: 18796547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.